Similarly, in patients with clear cell renal cell carcinoma (ccRCC), higher IFIT2 expression correlated with improved overall survival, compared to patients with lower IFIT2 expression [56]. This evidence concerns the gene IFIT2 and nonpapillary renal cell carcinoma.